(Q44525697)

3 December 2017

title

Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma (English)

1 reference

3 December 2017

1 reference

Lange B

1

1 reference

3 December 2017

Schroeder U

2

1 reference

3 December 2017

Huebener N

3

1 reference

3 December 2017

Jikai J

4

1 reference

3 December 2017

Wenkel J

5

1 reference

3 December 2017

Strandsby A

6

1 reference

3 December 2017

Wrasidlo W

7

1 reference

3 December 2017

Gaedicke G

8

1 reference

3 December 2017

Lode HN

9

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

197

1 reference

3 December 2017

issue

1-2

1 reference

3 December 2017

page(s)

225-230

1 reference

A novel hypothesis for the mechanism of action of P-glycoprotein as a multidrug transporter

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900106-X

7 January 2021

P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900106-X

7 January 2021

Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900106-X

7 January 2021

Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900106-X

7 January 2021

Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900106-X

7 January 2021

MDR1/P-glycoprotein in haematological neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900106-X

7 January 2021

Synthesis, hydrolytic activation and cytotoxicity of etoposide prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900106-X

7 January 2021

Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900106-X

7 January 2021

JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900106-X

7 January 2021

Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900106-X

7 January 2021

10.1016/S0304-3835(03)00106-X

Identifiers

DOI

1 reference

3 December 2017

1 reference